CYP19A1 and breast carcinoma: Aromatase is the rate-limiting enzyme for estrogen synthesis, and leptin can induce aromatase expression through COX-2 expression in breast cancer cells and increase estrogen synthesis, promoting the progression of breast cancer (51, 52).